Combining Dinutuximab with ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2+ Pediatric Solid Tumors (ST)
2018 ◽
Vol 24
(3)
◽
pp. S472-S473
Keyword(s):
Ex Vivo
◽